Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Top Cited Papers
Open Access
- 22 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 36 (6), 1115-1130
- https://doi.org/10.1093/schbul/sbp031
Abstract
Objective: Our aim was to review recent studies and estimate the rate of cannabis use disorders (CUDs) in schizophrenia, as well as to examine the factors affecting this rate. Methods: We conducted an electronic search of 3 literature databases and a manual search of articles from 1996 to 2008. The key words used were “schizophreni*,” “psychos*s,” “psychotic,” “cannabis abuse,” “cannabis dependence,” “cannabis use disorder,” “substance use disorder,” “substance abuse,” “substance dependence,” and “dual diagnosis.” Articles that reported diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases were included. Regression analysis was used to examine how estimated rates of CUDs are affected by various study characteristics such as the classification system, inpatient vs outpatient status, study location, proportion of males, age of the sample, or duration of illness. Results: Thirty-five studies met our search criteria. The median current rate of CUDs was 16.0% (interquartile range [IQR] = 8.6–28.6, 10 studies), and the median lifetime rate was 27.1% (IQR = 12.2–38.5, 28 studies). The median rate of CUDs was markedly higher in first-episode vs long-term patients (current 28.6%/22.0%, lifetime 44.4%/12.2%, respectively) and in studies where more than two-thirds of the participants were males than in the other studies (33.8%/13.2%). CUDs were also more common in younger samples than in the others (current 38.5%/16.0%, lifetime 45.0%/17.9%). Conclusions: Approximately every fourth schizophrenia patient in our sample of studies had a diagnosis of CUDs. CUDs were especially common in younger and first-episode patient samples as well as in samples with a high proportion of males.Keywords
This publication has 56 references indexed in Scilit:
- Effects of cannabis use on outcomes of psychotic disorders: systematic reviewThe British Journal of Psychiatry, 2008
- Drug use and health among prison inmatesCurrent Opinion in Psychiatry, 2008
- Factors Affecting Hospital Length of Stay: Is Substance Use Disorder One of Them? A Study in a Greek Public Psychiatric HospitalThe American Journal on Addictions, 2008
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewThe Lancet, 2007
- Substance use in a population-based clinic sample of people with first-episode psychosisThe British Journal of Psychiatry, 2007
- The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosisAddiction, 2006
- Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addictionSchizophrenia Research, 2006
- Methods for Analysis of Skewed Data Distributions in Psychiatric Clinical Studies: Working With Many Zero ValuesAmerican Journal of Psychiatry, 2004
- Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sampleSchizophrenia Research, 2004
- Motivation to Quit Using Substances Among Individuals With Schizophrenia: Implications for a Motivation-based Treatment ModelSchizophrenia Bulletin, 1997